ESLT Stock Analysis: Elbit Systems | NASDAQ

Aerospace, Cyber Intelligence, Electronic Warfare, Weapon

Total Rating 64

Safety 81

Buy Signal -0.12

Aerospace & Defense
Industry Rotation: +2.2

Market Cap: 34.5B
Avg Turnover: 67.5M

Risk 3d forecast

Volatility42.3%

VaR 5^th Pctl6.85%

VaR vs Median-1.64%

Reward TTM

Sharpe Ratio1.12

Rel. Str. IBD57.8

Rel. Str. Peer Group74.6 pctl

Character TTM

Beta0.096

Beta Downside-0.585

Hurst Exponent0.554

Choppyness67.0%

Drawdowns 3y

Max DD35.39%

CAGR/Max DD1.64

CAGR/Mean DD6.34

EPS (Earnings per Share)

EPS CAGR: 39.91%
EPS Trend: 98.6%

Last SUE: 2.55
Qual. Beats: 10

Revenue

Rev. CAGR: 15.55%
Rev. Trend: 99.6%

Last SUE: 0.04
Qual. Beats: 0

Warnings

Below Sma 200d

Tailwinds

Confidence

Seasonality 11.7 years of data

Jan +3.9% 19

Feb +1.2% 10

Mar +2.1% 11

Apr -1.0% 10

May -0.5% 10

Jun -0.1% 5

Jul +1.0% 27

Aug -1.9% 20

Sep -0.6% 5

Oct -2.0% 12

Nov +0.3% 0

Dec +2.6% 17

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: ESLT Elbit Systems

Elbit Systems Ltd. (NASDAQ: ESLT) is an Israeli defense and homeland security company that develops and supplies a broad portfolio of products and services across five reporting segments: Aerospace; C4I and Cyber; Intelligence, Surveillance, Target Acquisition and Reconnaissance (ISTAR) and Electronic Warfare; Land; and Elbit Systems of America. Its offerings span airborne platforms, unmanned aerial systems, precision-guided munition sensors, command-and-control and communications systems, cyber intelligence, electro-optic and laser solutions, naval combat management, electronic warfare and radar systems, and land-based weapons and active protection systems. The company serves governments and commercial customers across Israel, North America, Europe, the Asia-Pacific, and Latin America, and was founded in 1966, headquartered in Haifa, Israel.

As a major non-U.S. defense prime contractor, Elbit competes in the global defense electronics market alongside larger U.S. and European peers, and like most defense companies, its revenue is heavily dependent on government procurement contracts, particularly from the Israeli Ministry of Defense and allied nations. The Israeli defense sector is one of the worlds largest arms exporters, and Elbits diversified segment structure allows it to address both traditional military demand and growing adjacent markets such as homeland security, commercial aviation, and medical instrumentation.

Headlines to Watch Out For

Israeli defense spending rises amid regional conflicts
US defense contracts expand through Elbit Systems of America segment
European defense budgets increase following Russia-Ukraine war

Piotroski VR-10 (Strict) 6.5

Net Income: 636.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.30 > 1.0
NWC/Revenue: 29.37% < 20% (prev 21.64%; Δ 7.72% < -1%)
CFO/TA 0.07 > 3% & CFO 1.01b > Net Income 636.0m
Net Debt (474.0m) to EBITDA (927.7m): 0.51 < 3
Current Ratio: 1.39 > 1.5 & < 3
Outstanding Shares: last quarter (48.1m) vs 12m ago 3.06% < -2%
Gross Margin: 25.03% > 18% (prev 24.02%; Δ 1.01% > 0.5%)
Asset Turnover: 65.85% > 50% (prev 62.13%; Δ 3.72% > 0%)
Interest Coverage Ratio: 6.04 > 6 (EBIT TTM 748.0m / Interest Expense TTM 123.9m)

Altman Z'' 2.81

A: 0.18 (Total Current Assets 8.87b - Total Current Liabilities 6.36b) / Total Assets 13.9b
B: 0.23 (Retained Earnings 3.15b / Total Assets 13.9b)
C: 0.06 (EBIT TTM 748.0m / Avg Total Assets 13.0b)
D: 0.47 (Book Value of Equity 4.41b / Total Liabilities 9.45b)
Altman-Z'' = 2.81 = A

Beneish M -3.00

DSRI: 1.04 (Receivables 4.17b/3.53b, Revenue 8.55b/7.52b)
GMI: 0.96 (GM 24.02% / 25.03%)
AQI: 0.89 (AQ_t 0.22 / AQ_t-1 0.24)
SGI: 1.14 (Revenue 8.55b / 7.52b)
TATA: -0.03 (NI 636.0m - CFO 1.01b) / TA 13.9b)
Beneish M = -3.00 (Cap -4..+1) = A

What is the price of ESLT shares?

As of November 03, 2026, the stock is trading at USD 742.47 with a total of 125,397 shares traded. Over the past week, the price has changed by -4.56%, over one month by +6.80%, over three months by -10.42% and over the past year by +55.18%.

Current recommended Stop Loss: 704.10 (which is 5.2% or 1.6 ATR below the current price).

Is ESLT a buy, sell or hold?

Elbit Systems has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold ESLT.

StrongBuy: 1
Buy: 0
Hold: 5
Sell: 0
StrongSell: 0

What are the forecasts/targets for the ESLT price?

Analysts Target Price	802.2	8%

Elbit Systems (ESLT) - Fundamental Data Overview as of 27 October 2026

Market Cap USD = 34.5b (34.5b USD * 1.0 USD.USD)
P/E Trailing = 55.3303
P/E Forward = 9.6618
P/S = 4.0326
P/B = 7.9209
P/EG = 8.7866
Revenue TTM = 8.55b USD
EBIT TTM = 748.0m USD
EBITDA TTM = 927.7m USD
Long Term Debt = 180.0m USD (from longTermDebt, last quarter)
Short Term Debt = 184.5m USD (from shortTermDebt, last quarter)
Debt = 1.44b USD (from shortLongTermDebtTotal, last quarter) + Leases 584.7m
Net Debt = 474.0m USD (calculated: Debt 1.44b - CCE 962.9m)
Enterprise Value = 34.9b USD (34.5b + Debt 1.44b - CCE 962.9m)
Interest Coverage Ratio = 6.04 (Ebit TTM 748.0m / Interest Expense TTM 123.9m)
EV/FCF = 50.43x (Enterprise Value 34.9b / FCF TTM 692.8m)
FCF Yield = 1.98% (FCF TTM 692.8m / Enterprise Value 34.9b)
FCF Margin = 8.11% (FCF TTM 692.8m / Revenue TTM 8.55b)
Net Margin = 7.44% (Net Income TTM 636.0m / Revenue TTM 8.55b)
Gross Margin = 25.03% ((Revenue TTM 8.55b - Cost of Revenue TTM 6.41b) / Revenue TTM)
Gross Margin QoQ = 25.32% (prev 25.22%)
Tobins Q-Ratio = 2.52 (Enterprise Value 34.9b / Total Assets 13.9b)
Interest Expense / Debt = 8.62% (Interest Expense 123.9m / Debt 1.44b)
Taxrate = 12.13% (87.9m / 724.5m)
NOPAT = 657.3m (EBIT 748.0m * (1 - 12.13%))
Current Ratio = 1.39 (Total Current Assets 8.87b / Total Current Liabilities 6.36b)
Debt / Equity = 0.33 (Debt 1.44b / totalStockholderEquity, last quarter 4.41b)
Debt / EBITDA = 0.51 (Net Debt 474.0m / EBITDA 927.7m)
Debt / FCF = 0.68 (Net Debt 474.0m / FCF TTM 692.8m)
Total Stockholder Equity = 4.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.90% (Net Income 636.0m / Total Assets 13.9b)
RoE = 15.13% (Net Income TTM 636.0m / Total Stockholder Equity 4.20b)
RoCE = 17.06% (EBIT 748.0m / Capital Employed (Equity 4.20b + L.T.Debt 180.0m))
RoIC = 9.05% (NOPAT 657.3m / Invested Capital 7.26b)
WACC = 6.03% (E(34.5b)/V(35.9b) * Re(5.97%) + D(1.44b)/V(35.9b) * Rd(8.62%) * (1-Tc(0.12)))
Discount Rate = 5.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 95.70 | Cagr: 3.38%
[DCF] Terminal Value 76.45% ; FCFF base≈671.9m ; Y1≈720.2m ; Y5≈869.2m
[DCF] Fair Price = 274.5 (EV 13.3b - Net Debt 474.0m = Equity 12.9b / Shares 46.9m; r=8.35% [WACC [floored]]; 5y FCF grow 8.15% → 2.50% )
EPS Correlation: 98.63 | EPS CAGR: 39.91% | SUE: 2.55 | # QB: 10
Revenue Correlation: 99.65 | Revenue CAGR: 15.55% | SUE: 0.04 | # QB: 0
EPS current Quarter (2026-09-30): EPS=3.94 | Chg30d=+1.14% | Revisions=+17% | Analysts=4
EPS current Year (2026-12-31): EPS=16.38 | Chg30d=+0.73% | Revisions=+40% | GrowthEPS=+28.5% | GrowthRev=+15.0%
EPS next Year (2027-12-31): EPS=18.61 | Chg30d=+1.36% | Revisions=+40% | GrowthEPS=+13.6% | GrowthRev=+12.2%
[Analyst] Revisions Ratio: +50% (up=6, down=1)